Assyro AI

FDA Orange Book · active-ingredient family

Thalidomide

Thalidomide is approved as 1 brand and 1 generic application in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:THALOMID · NDA 020785

1

Brand (NDA)

1

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · capsule

ProductApplicantApplicationTEApproved
THALOMIDRLD×4BRISTOL-MYERSNDA 020785ABJul 16, 1998

Generic (ANDA) products (1)

ProductApplicantApplicationTEApproved
THALIDOMIDE×4NATCOANDA 213267ABApr 24, 2026

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Thalidomide — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.